News Daily News Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA The trial yields yet more data supporting the use of CCTA when it comes to risk stratification of patients with stable CAD. Michael O'Riordan March 14, 2024
Presentation THT 2024 Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock Presenter: James Schurr March 06, 2024
Presentation THT 2024 A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms. Presenter: Thomas Hanff March 06, 2024
Presentation THT 2024 DPP3-Based Biotherapy in Cardiogenic Shock Presenter: Mahir Karakas March 06, 2024
News Daily News US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users By Caitlin E. Cox March 18, 2024
News Conference News CRT 2024 SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI By L.A. McKeown March 15, 2024
News Daily News Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA By Michael O'Riordan March 14, 2024
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries By L.A. McKeown March 14, 2024
News Daily News Physicians (Mostly) Negative on Private Equity in Healthcare By Michael O'Riordan March 13, 2024